par Piccart-Gebhart, Martine
Référence Anti-cancer drugs, 6 Suppl 4, page (7-11)
Publication Publié, 1995-07
Référence Anti-cancer drugs, 6 Suppl 4, page (7-11)
Publication Publié, 1995-07
Article révisé par les pairs
Titre: |
|
Auteur: | Piccart-Gebhart, Martine |
Informations sur la publication: | Anti-cancer drugs, 6 Suppl 4, page (7-11) |
Statut de publication: | Publié, 1995-07 |
Sujet CREF: | Sciences bio-médicales et agricoles |
MeSH keywords: | Antineoplastic Agents -- therapeutic use |
Antineoplastic Agents, Phytogenic -- adverse effects | |
Antineoplastic Agents, Phytogenic -- therapeutic use | |
Breast Neoplasms -- drug therapy | |
Breast Neoplasms -- mortality | |
Breast Neoplasms -- pathology | |
Clinical Trials, Phase II as Topic | |
Doxorubicin -- therapeutic use | |
Female | |
Humans | |
Liver Neoplasms -- drug therapy | |
Liver Neoplasms -- secondary | |
Middle Aged | |
Multicenter Studies as Topic | |
Neoplasm Staging | |
Paclitaxel -- adverse effects | |
Paclitaxel -- analogs & derivatives | |
Paclitaxel -- therapeutic use | |
Survival Rate | |
Taxoids | |
Note générale: | Comparative Study |
Journal Article | |
Review | |
SCOPUS: re.j | |
Langue: | Anglais |
Identificateurs: | urn:issn:0959-4973 |
info:scp/0029563129 | |
info:pmid/8745348 |